Related Experiment Video

Updated: Jun 11, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
12:41

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat

Published on: August 28, 2021

Tiered Approach to Clonidine Dosing to Prevent Dexmedetomidine Withdrawal in Children: A Prospective Pre and Post

Andrea L Heifner1, Weng M Lam2, Monica Lee3

  • 1Department of Pediatrics, Pediatric Critical Care (ALH, JNN, TLN), University of Texas Health Science Center at Houston, Houston, TX.

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|June 10, 2026
PubMed

Insights

A new clonidine dosing protocol showed a trend towards reduced dexmedetomidine withdrawal in pediatric patients. This protocol facilitated faster weaning from dexmedetomidine, suggesting potential benefits in managing withdrawal symptoms.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology and therapeutics
  • Clinical trial methodology

Background:

  • Dexmedetomidine is commonly used for sedation in pediatric intensive care units.
  • Withdrawal syndromes can occur after prolonged dexmedetomidine infusions.
  • Current strategies for preventing dexmedetomidine withdrawal are varied.

Purpose of the Study:

  • To evaluate the effectiveness of a tiered enteral clonidine dosing protocol in reducing dexmedetomidine withdrawal.
  • To compare withdrawal incidence before and after protocol implementation.
  • To assess the impact of the protocol on dexmedetomidine weaning time.

Main Methods:

  • Pre- and postinterventional cohort study design.
  • Data collected over two 6-month periods.
  • Patients received dexmedetomidine for ≥72 hours.
  • Withdrawal defined by specific hemodynamic and clinical signs.

Main Results:

  • No significant difference in overall withdrawal incidence between phases.
  • A trend towards reduced withdrawal in patients receiving clonidine during the intervention phase (36% vs 52%).
  • Increased proportion of patients weaned off dexmedetomidine within 24 hours in the intervention phase (67% vs 39%).

Conclusions:

  • This is the first prospective study on an enteral clonidine protocol for dexmedetomidine withdrawal in children.
  • The protocol demonstrated a trend towards reduced withdrawal.
  • Faster dexmedetomidine weaning was achieved with similar drug exposure.
Abstract

Keywords:
adrenergic alpha agonistsclonidinedexmedetomidinepediatric ICUpediatricswithdrawal symptoms

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...